PI3K/AKT/mTOR Signaling Pathway Is Required for JCPyV Infection in Primary Astrocytes

被引:8
|
作者
Wilczek, Michael P. [1 ]
Armstrong, Francesca J. [1 ]
Mayberry, Colleen L. [1 ]
King, Benjamin L. [1 ,2 ]
Maginnis, Melissa S. [1 ,2 ]
机构
[1] Univ Maine, Dept Mol & Biomed Sci, Orono, ME 04469 USA
[2] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA
基金
美国国家卫生研究院;
关键词
JC polyomavirus; PML; astrocytes; SVGA cells; primary cells; PI3K; AKT; mTOR; rapamycin; wortmannin; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; LARGE T-ANTIGEN; JC VIRUS-DNA; MATRIX-METALLOPROTEINASE EXPRESSION; MULTIPLE-SCLEROSIS; BK POLYOMAVIRUS; GENE-EXPRESSION; CELL BIOLOGY; GLIAL-CELLS; PROTEIN;
D O I
10.3390/cells10113218
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Astrocytes are a main target of JC polyomavirus (JCPyV) in the central nervous system (CNS), where the destruction of these cells, along with oligodendrocytes, leads to the fatal disease progressive multifocal leukoencephalopathy (PML). There is no cure currently available for PML, so it is essential to discover antivirals for this aggressive disease. Additionally, the lack of a tractable in vivo models for studying JCPyV infection makes primary cells an accurate alternative for elucidating mechanisms of viral infection in the CNS. This research to better understand the signaling pathways activated in response to JCPyV infection reveals and establishes the importance of the PI3K/AKT/mTOR signaling pathway in JCPyV infection in primary human astrocytes compared to transformed cell lines. Using RNA sequencing and chemical inhibitors to target PI3K, AKT, and mTOR, we have demonstrated the importance of this signaling pathway in JCPyV infection of primary astrocytes not observed in transformed cells. Collectively, these findings illuminate the potential for repurposing drugs that are involved with inhibition of the PI3K/AKT/mTOR signaling pathway and cancer treatment as potential therapeutics for PML, caused by this neuroinvasive virus.
引用
收藏
页数:25
相关论文
共 50 条
  • [21] Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
    Kawauchi, Kiyotaka
    Ogasawara, Toshie
    Yasuyama, Masako
    Otsuka, Kuniaki
    Yamada, Osamu
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (09) : 1024 - 1038
  • [22] PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
    Antonino Glaviano
    Aaron S. C. Foo
    Hiu Y. Lam
    Kenneth C. H. Yap
    William Jacot
    Robert H. Jones
    Huiyan Eng
    Madhumathy G. Nair
    Pooyan Makvandi
    Birgit Geoerger
    Matthew H. Kulke
    Richard D. Baird
    Jyothi S. Prabhu
    Daniela Carbone
    Camilla Pecoraro
    Daniel B. L. Teh
    Gautam Sethi
    Vincenzo Cavalieri
    Kevin H. Lin
    Nathalie R. Javidi-Sharifi
    Eneda Toska
    Matthew S. Davids
    Jennifer R. Brown
    Patrizia Diana
    Justin Stebbing
    David A. Fruman
    Alan P. Kumar
    Molecular Cancer, 22
  • [23] PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
    Leiphrakpam, Premila D.
    Are, Chandrakanth
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [24] The PI3K/AKT/mTOR signaling pathway: Implications in the treatment of breast cancer
    Andreopoulou E.
    Current Breast Cancer Reports, 2011, 3 (1) : 63 - 74
  • [25] The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway
    Yao, Hong
    Han, Xiangyang
    Han, Xiuzhen
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2014, 14 (06) : 433 - 442
  • [26] Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer
    Akbarzadeh, Maryam
    Mihanfar, Ainaz
    Akbarzadeh, Shabnam
    Yousefi, Bahman
    Majidinia, Maryam
    LIFE SCIENCES, 2021, 285
  • [27] PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
    Glaviano, Antonino
    Foo, Aaron S. C.
    Lam, Hiu Y.
    Yap, Kenneth C. H.
    Jacot, William
    Jones, Robert H.
    Eng, Huiyan
    Nair, Madhumathy G.
    Makvandi, Pooyan
    Geoerger, Birgit
    Kulke, Matthew H.
    Baird, Richard D.
    Prabhu, Jyothi S.
    Carbone, Daniela
    Pecoraro, Camilla
    Teh, Daniel B. L.
    Sethi, Gautam
    Cavalieri, Vincenzo
    Lin, Kevin H.
    Javidi-Sharifi, Nathalie R.
    Toska, Eneda
    Davids, Matthew S.
    Brown, Jennifer R.
    Diana, Patrizia
    Stebbing, Justin
    Fruman, David A.
    Kumar, Alan P.
    MOLECULAR CANCER, 2023, 22 (01)
  • [28] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    HaiXia Li
    JianFang Zeng
    Keng Shen
    Archives of Gynecology and Obstetrics, 2014, 290 : 1067 - 1078
  • [29] The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway
    Hong Yao
    Xiangyang Han
    Xiuzhen Han
    American Journal of Cardiovascular Drugs, 2014, 14 : 433 - 442
  • [30] mTOR/PI3k/Akt SIGNALING PATHWAY IN TUMOR ANGIOGENESIS AND THERAPEUTIC TARGETING
    Mabeta, Peace
    Davis, Paul F.
    Pepper, Michael S.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6042 - 6042